What is Healthcare Global Enterprises Ltd's market cap?

Healthcare Global Enterprises Ltd (HCG) has a market capitalization of ₹9,697 Cr.

What sector is HCG in?

Healthcare Global Enterprises Ltd operates in the Healthcare — Hospitals & Diagnostics sector.

What is HCG's return on equity?

Healthcare Global Enterprises Ltd has a return on equity (ROE) of 2.1%.

Loading company...

Analyzing...

Healthcare Global Enterprises Ltd (HCG) — Analysis, Financials, Intelligence | The Stock Filter

The Organism · Company Intelligence

Healthcare Global Enterprises Ltd

HCG|BSE: 539787

Healthcare — Hospitals & DiagnosticsHealthcare & Life Scienceswww.hcgoncology.com

₹627.90

₹0.15 (-0.02%)|MCap ₹9,697 Cr

As of 16 Jun 2026 (End of Day)

52W Low ₹513.3052W High ₹799.71

HealthCare Global Enterprises Ltd. provides imaging and diagnostics services for cancer treatment. The company is headquartered in Bangalore, Karnataka and currently employs 5,679 full-time employees.

Secular Currents

Theme Connections

Healthcare Access Insurance Penetration Premiumisation

Intelligence Profile

TSF Score

62/100

The Vitals · Company Health

Health Indicators

Shenanigan Score

37Medium

Trust Score

X-Ray

Concerns

🟠Below-average return on equity (2.1%)Business
🟠Profit decliningBusiness

Watch

Nothing flagged for monitoring

Strengths

🟢Healthy revenue growth (17.0% CAGR 3yr)Business

The Numbers · Key Metrics

ROE

2.1%

Revenue Growth 3yr

17.0%

Debt/Equity

0.98x

₹9,461 Cr

The Narrator · StoryTel Intelligence

FY2025Healthcare — Hospitals & DiagnosticsProduct Sales ModelModel:Revenue = Number of Patients × Average Revenue per Patient (ARPOB for hospitals; Revenue per Test for diagnostics)

Key Insight

“Services business in Healthcare — Hospitals & Diagnostics.”

The Revenue Story

₹2,223 Cr service revenue.

Total Income₹2,258 Cr

Revenue₹2,223 Cr(98.5% of Total Income)

Other Income₹35 Cr(1.5% of Total Income)

The Cost Story

Employee costs at 15.9% of revenue — primary cost driver.

EBITDA₹968 Cr(37.4%)

Other Expenses₹901 Cr(34.8%)

Employee₹353 Cr(13.7%)

Depreciation₹211 Cr(8.2%)

Finance Costs₹155 Cr(6.0%)

0.2%EBITDA Margin

EBITDA

37.4%

Other Expenses

34.8%

Employee

13.7%

Depreciation

8.2%

Finance Costs

6.0%

Key Metrics

ROE

2.1%

vs median 7.9%

ROCE

8.5%

vs median 11.3%

Net Margin

0.8%

vs median 9.3%

EBITDA Margin

18.2%

vs median 21.9%

Debt To Equity

0.98x

vs median 0.16x

Rev Growth 3yr

17.0%

vs median 12.4%

EPS Growth 3yr

-6.2%

vs median 11.8%

Employee Cost Ratio

15.90x

The Context · Where does it sit?

Sector Context

The Canopy · Sector KPIs

Sector KPIs

Healthcare — Hospitals & Diagnostics

KPI	Company	Sector Median
ROE	2.1%▼	7.9%
ROCE	8.5%▼	11.3%
Net Margin	0.8%▼	9.3%
EBITDA Margin	18.2%▼	21.9%
Debt To Equity	0.98x▲	0.16x
Rev Growth 3yr	17.0%▲	12.4%
EPS Growth 3yr	-6.2%▼	11.8%
Employee Cost Ratio	15.90x	-

The Market · What is the market saying?

Market Signals

The Antenna · Media Intelligence

Media Signal

Low Impact

7d+0.44→30d+0.44

Based on 1 article (0 in last 7 days)

The Numbers · Show me the data

Financials

No valuation data

Historical valuation data not available.

Financials

Revenue₹2,478 Cr

PBT₹38 Cr

EPS₹1.28

(₹ Cr)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	₹2,478 Cr +11.5%	₹2,223 Cr +16.3%	₹1,912 Cr +12.8%	₹1,694 Cr +21.2%	₹1,398 Cr +37.9%	₹1,013 Cr -7.5%	₹1,096 Cr +12.3%	₹976 Cr
Other Income	₹22 Cr -36.4%	₹35 Cr +105.5%	₹17 Cr +28.5%	₹13 Cr +4.0%	₹13 Cr -25.3%	₹17 Cr +143.2%	₹7 Cr -30.7%	₹10 Cr
Total Income	₹2,500 Cr +10.8%	₹2,258 Cr +17.0%	₹1,929 Cr +13.0%	₹1,708 Cr +21.1%	₹1,410 Cr +36.9%	₹1,030 Cr -6.5%	₹1,103 Cr +11.8%	₹986 Cr
COGS	₹670 Cr +15.3%	₹581 Cr +22.1%	₹475 Cr +12.1%	₹424 Cr +19.5%	₹355 Cr +47.7%	₹240 Cr +0.2%	₹240 Cr +9.7%	₹219 Cr
	₹2,449 Cr +11.3%	₹2,201 Cr +18.0%	₹1,866 Cr +12.2%	₹1,663 Cr +17.4%	₹1,416 Cr +21.5%	₹1,165 Cr -3.7%	₹1,210 Cr +19.9%	₹1,008 Cr
Profit Before Tax	₹38 Cr -31.6%	₹56 Cr -16.5%	₹67 Cr +50.0%	₹45 Cr -49.7%	₹89 Cr ↑ Recovery	(₹228 Cr) -113.5%	(₹107 Cr) -377.4%	(₹22 Cr)
Exceptional Items	(₹13 Cr)	₹0.00 Cr -100.0%	₹4 Cr	₹0.00 Cr -100.0%	₹95 Cr ↑ Recovery	(₹93 Cr)	₹0.00 Cr	₹0.00 Cr
	₹14 Cr +69.5%	₹8 Cr -69.2%	₹26 Cr -3.1%	₹27 Cr -44.2%	₹49 Cr ↑ Recovery	(₹8 Cr) ↓ Decline	₹6 Cr ↑ Recovery	(₹3 Cr)
Net Profit	₹26 Cr -47.8%	₹49 Cr +18.2%	₹41 Cr +134.5%	₹18 Cr -54.7%	₹39 Cr ↑ Recovery	(₹221 Cr) -76.2%	(₹125 Cr) -306.3%	(₹31 Cr)
Profit (Owners)	₹19 Cr -57.3%	₹44 Cr -7.7%	₹48 Cr +64.1%	₹29 Cr -45.4%	₹54 Cr ↑ Recovery	(₹193 Cr) -81.3%	(₹107 Cr) -330.2%	(₹25 Cr)
Minority Interest	₹7 Cr +48.4%	₹4 Cr ↑ Recovery	(₹7 Cr) +41.8%	(₹12 Cr) +20.9%	(₹15 Cr) +46.4%	(₹28 Cr) -47.3%	(₹19 Cr) -208.6%	(₹6 Cr)
Other Comprehensive Income	₹3 Cr +72.8%	₹2 Cr ↑ Recovery	(₹0.47 Cr) +64.4%	(₹1 Cr) +13.7%	(₹2 Cr) ↓ Decline	₹0.59 Cr +22.9%	₹0.48 Cr ↑ Recovery	(₹3 Cr)
EPS	₹1.28	₹3.01	₹3.26	₹1.99	₹3.65	(₹14.58)	(₹11.36)	(₹2.66)
Diluted Shares	₹15 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹13 Cr	₹9 Cr	₹9 Cr
Profit Or Loss Of Associates	₹0.85 Cr +10.4%	₹0.77 Cr +97.4%	₹0.39 Cr ↑ Recovery	(₹0.02 Cr) +98.6%	(₹1 Cr) -300.0%	(₹0.36 Cr) +97.1%	(₹12 Cr) -12.2%	(₹11 Cr)